Physician Assistant · Riverside, CA
NPI
1871618371
Since 2007
Specialty
Physician Assistant
Code 363A00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
10800 Magnolia Ave
Riverside, CA, 92505
Phone (909) 353-2000
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$489K
1,034 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Helina Michael prescribed most often to Medicare patients was Ozempic (Semaglutide), with 182 prescriptions and refills. In total Helina Michael wrote 1,034 Medicare prescriptions that cost $489K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-15.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Ozempic Semaglutide | 182 | 188 | 52 | $137K |
| Humulin N Kwikpen Insulin Nph Human Isophane | 103 | 295 | 72 | $26K |
| Humulin R Insulin Regular, Human | 88 | 250 | 54 | $17K |
| Humulin N Insulin Nph Human Isophane | 84 | 254 | 50 | $17K |
| Humulin 70/30 Kwikpen Insulin Nph Hum/Reg Insulin Hm | 66 | 188 | 44 | $21K |
| Insulin Glargine-Yfgn Generic | 62 | 180 | 43 | $11K |
| Glipizide Generic | 52 | 172 | 32 | $640 |
| Humulin R U-500 Kwikpen Insulin Regular, Human | 51 | 153 | 35 | $138K |
| Liraglutide Generic | 47 | 56 | 28 | $34K |
| Humalog Kwikpen U-100 Insulin Lispro | 44 | 123 | 32 | $18K |
| Victoza 2-Pak Liraglutide | 36 | 38 | 13 | $23K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 28 | 53 | 18 | $606 |
| Humulin 70-30 Insulin Nph Hum/Reg Insulin Hm | 22 | 72 | 15 | $8,881 |
| Metformin Hcl Er Metformin Hcl | 19 | 49 | 13 | $189 |
| Metformin Hcl Generic | 17 | 54 | Under 11 | $202 |
Brand drugs: 826 claims; generic drugs: 168 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Helina Michael were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.